The AHA today urged the Centers for Medicare & Medicaid Services not to resume medical review activities, including Recovery Audit Contractor-initiated audits, which CMS suspended on March 30 due to the COVID-19 public health emergency.

AHA expressed deep concern with the agency’s decision to resume on Aug. 3 these burdensome audits in the middle of an ongoing pandemic.

“Requiring hospitals on the front line to divert their time, attention and resources away from patient care toward managing medical reviews – especially in the case of reviews conducted by RACs, which are paid on a contingency fee basis and thus incentivized to make inappropriate denials – will have a detrimental effect on their ability to manage the pandemic for their communities at the very time when it is needed most,” AHA wrote.

Read AHA’s full letter.

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Chairperson's File
Public
This month Congress enacted the One Big Beautiful Bill Act — a sweeping package that contained many of President Trump’s legislative priorities on taxes,…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The House July 3 voted 218-214 to pass the final version of the One Big Beautiful Bill Act (H.R. 1), which enacts many of President Trump’s legislative…
Headline
The House has begun consideration of the Senate-passed version of the One Big Beautiful Bill Act (H.R. 1). This continues to be a fluid…
Headline
The Senate narrowly passed the One Big Beautiful Bill Act (H.R. 1) on July 1 by a 50-50 tally, with Vice President J.D. Vance casting the tie-breaking vote.…